ADM Tronics Reports Second Quarter of Fiscal Year 2027 Results
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ADM Tronics Unlimited (ADMT) reported fiscal second-quarter revenue of $941,671, up over 6.1% year over year, for the period ended September 30, 2026. Operating income rose to $146,650 from $2,553, and net income reached $140,661 versus a $114,672 loss.
For the six months ended September 30, 2026, revenue fell 2.8% to $1,807,926. Operating income increased to $125,995 from $111,787, while net income declined to $173,025 from $212,962.
Following an October 26 securities purchase agreement, the company raised $1,550,000 in gross proceeds on October 27 and 28 by issuing 15,500,000 common shares at $0.10 each and warrants for 7,750,000 shares. The private placement targets approximately $5.0 million in gross proceeds and terminates no later than December 31, 2026. The warrants are exercisable at $0.10 per share for five years.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major pointPrivate placement raised $1,550,000 gross on October 27 and 28, 2026. 26% of market cap
- Moderate pointSecond-quarter revenue increased over 6.1% to $941,671 from $887,498 a year earlier.
- Moderate pointSecond-quarter operating income rose to $146,650 from $2,553 a year earlier.
- Moderate pointSecond-quarter net income reached $140,661, versus a $114,672 loss a year earlier.
- Moderate pointSix-month operating income increased to $125,995 from $111,787 a year earlier.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Private placement targets approximately $5.0 million in gross proceeds and terminates no later than December 31, 2026. 84% of market cap
5 minor points
- Minor pointSecond-quarter gross profit increased to $508,888 from $375,797 a year earlier.
- Minor pointSecond-quarter cost of sales decreased to $432,783 from $511,701 a year earlier.
- Minor pointSecond-quarter operating expenses decreased to $362,238 from $373,244 a year earlier.
- Minor pointSix-month gross profit increased to $903,938 from $857,090 a year earlier.
- Minor pointSix-month cost of sales decreased to $903,988 from $1,004,083 a year earlier.
Negative
- Major pointIssuance of 15,500,000 common shares at $0.10 each diluted existing holders.
- Moderate pointSix-month revenue declined 2.8% to $1,807,926 from $1,861,173 a year earlier.
- Moderate pointSix-month net income decreased to $173,025 from $212,962 a year earlier.
- Minor pointSix-month operating expenses increased to $777,943 from $745,303 a year earlier.
- Minor pointSix-month total other income decreased to $49,030 from $102,675 a year earlier.
- Minor point. Forward-looking: it has not happened yet and may not happen.Warrants for 7,750,000 shares, exercisable at $0.10 per share for five years, create potential additional dilution.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NORTHVALE, NJ / ACCESS Newswire / November 16, 2026 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its second fiscal quarter ended September 30, 2026 of Fiscal Year 2027.
Revenues for the three months ended September 30, 2026 were
Revenues for the six months ended September 30, 2026 were
Subsequent Event - Private Placement
As previously reported, on October 26, 2026, the Company entered into a Securities Purchase Agreement with certain accredited investors for a private placement of common stock at
On October 27 and 28, 2026, the Company issued a total of 15,500,000 shares of common stock and warrants to purchase 7,750,000 shares, for gross proceeds of
Complete financial results are available in the Company's Quarterly Report on Form 10Q for September 30, 2026, available at www.sec.gov.
Financial Highlights
| Three Months Ended | Six Months Ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
Net revenues | $ | 941,671 | $ | 887,498 | $ | 1,807,926 | $ | 1,861,173 | ||||||||
Cost of sales | $ | 432,783 | $ | 511,701 | $ | 903,988 | $ | 1,004,083 | ||||||||
Gross Profit | $ | 508,888 | $ | 375,797 | $ | 903,938 | $ | 857,090 | ||||||||
Total operating expenses | $ | 362,238 | $ | 373,244 | $ | 777,943 | $ | 745,303 | ||||||||
Income (loss) from operations | $ | 146,650 | $ | 2,553 | $ | 125,995 | $ | 111,787 | ||||||||
Total other income (expense) | $ | 5,989 | $ | (117,225 | ) | $ | 49,030 | $ | 102,675 | |||||||
Net income (loss) | $ | 140,661 | $ | (114,672 | ) | $ | 173,025 | $ | 212,962 | |||||||
Basic and diluted per common share | $ | 0.00 | $ | (0.00 | ) | $ | 0.00 | $ | 0.00 | |||||||
Weighted average shares of common stock outstanding - basic and diluted | 67,588,492 | 67,588,492 | 67,588,492 | 67,588,492 | ||||||||||||
About ADMT
ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Electronic Medical Devices; Design, Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly, Safe, Water-Based Formulations. The Company's headquarters, laboratories, and FDA-Registered and ISO-13485 Certified medical device development and manufacturing operations are in Northvale, NJ. ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, for the research, development and commercialization of diversified technologies. Additional information is available at admtronics.com.
ADMT welcomes inquiries for its electronics and medical device contract engineering and manufacturing services at www.admteng.com.
To receive ADMT email updates, complete the form at https://admtronics.com/investor-relations/.
Except for historical information contained herein, the matters set forth in this news release are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT's filings with the SEC, news releases and other communications. The Company assumes no obligation to update the information contained in this news release.
Contact: Andre DiMino - 201-767-6040 - andre@admtronics.com
SOURCE: ADM Tronics Unlimited Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.